Zogenix reported $78.43M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Acura Pharmaceuticals ACUR:US 1.11M 6.57M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Aerie Pharmaceuticals AERI:US $ 118.13M 10.04M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Arena Pharmaceuticals ARNA:US $ 53.36M 11.48M
AstraZeneca AZN:LN 23649M 1427M
Becton, Dickinson and BDX:US $ 6626M 1123M
Biogen BIIB:US $ 4211.6M 864.4M
Cardinal Health CAH:US 26.5B 1.12B
Esperion Therapeutics ESPR:US $ 78.48M 4.16M
Flexion Therapeutics FLXN:US $ 43.99M 4.06M
GlaxoSmithKline GSK:LN 22417M 1030M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Heron Therapeutics HRTX:US $ 72.3M 9.85M
Intra Cellular Therapies ITCI:US $ 49.9M 0.53M
Marinus Pharmaceuticals MRNS:US $ 37.68M 20.98M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Revance Therapeutics RVNC:US $ 65.87M 7.63M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Teva Pharmaceutical TEVA:IT 11.82B 866M
Zogenix ZGNX:US $ 78.43M 9.09M